What price do you think MNTA would be at now if their percentage share of Lovenox revenues didn't change upon Amphastar/Watson's entry into the market? I would say that the price would be well into the $20s.
We disagree. MNTA would still be losing money, even with the original deal. I doubt that it would be in the 20s. Value will be driven by mCop approval (and hopefully eventually by the Baxter deal).
Market Data 
Markets 
AI
